Kaleida Capital

Kaleida Capital is an early-stage venture capital firm focused on neurotechnology and neuroscience innovation. The company invests in and supports companies that develop technologies for brain health, including AI/data analytics, diagnostics, biosensors, neuroimaging, neurostimulation, and drug discovery. The firm leverages the expertise of world-class engineers, investors, and policy leaders who have dedicated their careers to emerging technology for neuroscience innovation.